🟢 HCW Biologics is trading 6.7% up in after-hours trading with no confirmed company-specific catalyst

HCW Biologics is trading at $2.39, up 6.70% after the regular-session close, with no confirmed September 11 company-specific catalyst identified.

• Latest disclosed development: a September 8 distribution agreement with Akron Biotech for HCW11-006.
• A September 10 SEC filing was reported, but available details do not identify its contents or a new catalyst.
• Broader indexes gained more than 0.5%, providing a possible global risk-on backdrop.